Buy me a Coffee!!

Buy me a Coffee!!
Thank you!

Nephrotic syndrome

Nephrotic syndrome


āϞেāĻ–া Nephrotic syndrome āύি⧟ে। āĻ…āύ্āϤāϤ āĻšাāϜাāϰ āĻ–াāύেāĻ• āĻŦাāύাāύ āĻ­ুāϞ āφāĻ›ে। āϟাāχāĻĒেāϰ āϏāĻŽā§Ÿ āĻ­ুāϞ āĻšā§ŸেāĻ›ে āϝা āϏāĻŽā§Ÿ āϏ্āĻŦāϞ্āĻĒāϤা⧟ āĻ•াāϰেāĻ•āĻļāύ āĻ•āϰা āĻšā§Ÿ āύি। āϤাāχ āĻ•োāύ āĻŦাāύাāύে āϏāύ্āĻĻেāĻš āĻšāϞে āĻ…āĻŦāĻļ্āϝāχ āϏāĻ িāĻ• āĻŦাāύাāύ āϜেāύে āύিāύ 
.
āĻāĻ–াāύে āĻŽূāϞāϤ ā§Š āϟি NOTE āĻāĻ•āϤ্āϰ āĻ•āϰে āĻĒোāϏ্āϟ āĻ•āϰা- āϤাāχ āĻĒোāϏ্āϟ āϟি āĻŦ⧜।
āĻāϤো āĻŦ⧜ āĻĒোāϏ্āϟ āĻĒ⧜āϤে āύা āϚাāχāϞে āĻ•āĻŽেāύ্āϟ āĻ āĻĻেāĻ“ā§Ÿা āϞিংāĻ• āĻĨেāĻ•ে ā§Š āĻ–āύ্āĻĄে āĻĒ⧜āϤে āĻĒাāϰেāύ।
āϞেāĻ–াāϰ āϧāϰāύ āĻŦা āϏাāϜাāύো āφāĻŽাāϰ। āϤāĻŦে āϰেāĻĢাāϰেāύ্āϏ āĻĄ āύাāϜীāĻŦ āϞেāĻ•āϚাāϰ, āϞেāĻ•āϚুāϰিāĻ“ āĻ“ āĻĒ্āϝাāĻĨোāĻŽা āĻĨেāĻ•ে āύেāĻ“ā§Ÿা
-----------------------------------------------------------------------

-----------------------------------------------------------------------
āφāĻŽāϰা āϝāĻĻি āĻāĻ•েāĻŦাāϰে āĻļুāϰু āĻĨেāĻ•েāχ āĻļুāϰু āĻ•āϰি āϤাāĻšāϞে āĻŦāϞা āϝা⧟ āφāĻŽাāĻĻেāϰ āĻĻুāχ āĻ•িāĻĄোāύী āϤে āĻŽোāϟ ⧍.⧍.ā§Ģ āĻŽিāϞি⧟āύ āύেāĻĢ্āϰāύ āφāĻ›ে, āĻŽাāύে āĻāχ āĻāĻ•āχ āĻĒāϰিāĻŽাāύ āĻ—্āϞোāĻŽেāϰুāϞাāχ āφāĻ›ে
āĻāχ āĻ—্āϞোāĻŽেāϰুāϞাāχ āĻ—ুāϞো filtration āĻāϰ āĻ•াāϜ āĻ•āϰে।
āĻ›āĻŦিāϟা āϝāĻĻি āφāĻŽāϰা āĻĻেāĻ–ি- āϤাāĻšāϞে āωāĻĒāϰ āĻĨেāĻ•ে āύীāϚে āĻāĻ­াāĻŦে āφāĻŽāϰা āĻŦāϞāϤে āĻĒাāϰি āĻāχ structure āϟি
.
Affarent and effarent arteriol, āĻāϰ āύীāϚে endothelium āĻāϰ āύীāϚে glomerular basement membrane (G.B.M.) āφāϰ āϤাāϰ āύীāϚে āĻŦ্āϝোāĻŽ্āϝাāύ্āϏ āĻ•্āϝাāĻĒāϏুāϞ āĻ Podocyte (āĻ­িāϏেāϰাāϞ āĻāĻĒিāĻĨেāϞি⧟াāĻŽ) āφāϰ āĻĒ্āϝাāϰাāχāϟাāϞ āĻāĻĒিāĻĨেāϞি⧟াāĻŽ
āĻāĻ–āύ āĻ•োāύ āĻ•িāĻ›ু āĻĢিāϞ্āϟাāϰ āĻšā§Ÿে āύীāϚে āφāϏāϤে āĻšāϞে āĻ•ি āĻ•ি āĻŦ্āϝাāϰি⧟াāϰ āĻĒাāϏ āĻ•āϰে āφāϏ্āϤে āĻšā§Ÿ?
ā§§) āĻ•্āϝাāĻĒিāϞাāϰি āĻāϰ āĻŽাāĻেāϰ pore (20-30 nanometer)
⧍) podocyte āĻ slit (70-100 nanometer)
ā§Š) āφāϰ āĻ•্āϝাāĻĒিāϞাāϰি, GBM āĻŦা podocyte āĻ āĻĨাāĻ•া āύেāĻ—েāϟিāĻ­ āϚাāϰ্āϜ
āĻŽাāύে āĻ•োāύ āĻ•িāĻ›ু āϝāĻĻি āĻĒাāϏ āĻ•āϰāϤে āϚা⧟ āϤাāĻšāϞে āĻāχ āĻ–াāύে āϏāĻŦāĻĨেāĻ•ে āĻ›োāϟ pore āĻĒাāϏ āĻ•āϰে āφāϏāϤেāχ āĻšāĻŦে। āĻŽাāύে āĻŽিāύিāĻŽাāĻŽ 20 nanometer āĻāϰ āĻ•āĻŽ āĻšāϤে āĻšāĻŦে।
albumin āĻāχ āϏাāχāϜেāϰ āĻĨেāĻ•ে āĻ›োāϟ।
āĻāϰ āĻĢāϞে āϚাāχāϞে albumin āĻāχ pore āĻ­েāĻĻ āĻ•āϰে urine āĻ āϝেāϤে āĻĒাāϰে।
āĻ•িāύ্āϤু āϝা⧟ āύা। āĻ•াāϰāύ? āĻāϞ্āĻŦুāĻŽিāύ āĻāϰ āύেāĻ—েāϟিāĻ­ āϚাāϰ্āϜ āφāϰ āĻŦ্āϝাāϰি⧟াāϰ āĻāϰ āύেāĻ—েāϟিāĻ­ āϚাāϰ্āϜ
* minimal change disease āĻ āĻāχ āύেāĻ—েāϟিāĻ­ āϚাāϰ্āϜ (āĻŦ্āϝাāϰি⧟াāϰ āĻ āĻĨাāĻ•া) neutral āĻšā§Ÿে āϝা⧟।
.
.
āĻāĻ–āύ, āĻ•েāϏ āϏিāύাāϰিāĻ“ āύেāĻ“ā§Ÿা āϝাāĻ•
.
ā§Š āϜāύ āĻĒেāĻļেāύ্āϟ।
ā§§āĻŽ āĻĒেāĻļেāύ্āϟেāϰ āĻ—্āϞোāĻŽেāϰুāϞাāχ āĻ•োāύ āĻ•াāϰāύে āχāĻž্āϜুāϰি āĻšā§ŸেāĻ›ে- āϤāĻŦে āĻ•āĻŽ। āϧāϰে āύিāϞাāĻŽ + injury
āĻāϤে āϤাāϰ āĻ—্āϞোāĻŽেāϰুāϞাāϰ āĻ pore āĻ—ুāϞা āĻŦ⧜ āĻšā§Ÿে āϝাāĻŦে āĻĢāϞে āϚাāϰ্āϜ āĻāĻ•āχ āĻšāĻ“ā§Ÿা āϏāϤ্āϤ্āĻŦেāĻ“ Albumin loose āĻ•āϰāĻŦে
āĻ•েāύāύা āĻāϞ্āĻŦুāĻŽিāύ āĻāϰ āϏাāχāϜ āχ āϏāĻŦāĻĨেāĻ•ে āĻ›োāϟ (āĻ—্āϞোāĻŦিāωāϞিāύ āĻŦা āĻĢিāĻŦ্āϰিāύোāϜেāύ āĻĨেāĻ•ে)
āĻāχ āĻ…āĻŦāϏ্āĻĨাāĻ•ে āĻŦāϞা āϝাāĻŦে selective proteinuria
āĻāĻ–āύ āφāϰেāĻ• āĻĒেāĻļেāύ্āϟ āĻāϰ ++ āχāύāϜুāϰি āĻšāϞ
āĻāϤে pore āĻāϰ āϏাāχāϜ āφāϰো āĻŦ⧜ āĻšāϞ (āĻ—্āϞোāĻŽেāϰুāϞাāϰ āĻ āχāύāϜুāϰিāϰ āϜāύ্āϝ barrier āĻ•্āώāϤিāĻ—্āϰāϏ্āĻĨ āĻšāϞ āφāϰ āĻĢāϞে pore āĻŦ⧜ āĻšāϞ)
āĻāϤে āφāĻ—েāϰ āĻŽāϤāύ āχ albumin pass āĻ•āϰāϞো urine āĻ। āϏাāĻĨে globulin āĻ“ āϝাāĻŦে
āĻĢāϞে āĻāχ āĻ…āĻŦāϏ্āĻĨাāĻ•ে āĻŦāϞা āϝাāĻŦে non selective proteinuria
āĻāĻ–āύ ā§Šā§Ÿ āĻĒেāĻļেāύ্āϟেāϰ āĻ–ুāĻŦ āĻŦেāĻļি āχāύāϜুāϰি āĻšāϞ- āϧāϰāϞাāĻŽ +++ injury
āĻĢāϞে āϤাāϰ āĻ…āύেāĻ• āĻŦেāĻļি albumin pass āĻ•āϰāĻ›ে, āφāĻ—েāϰ āĻĒেāĻļেāύ্āϟ āĻĨেāĻ•ে āĻŦেāĻļি globulin pass āĻ•āϰāϞো
āϧāϰে āύিāϞাāĻŽ āĻāχ protein loose āĻ•āϰāĻ›ে āĻĻিāύে 3.5 gm/day āĻāϰ āĻĨেāĻ•ে āĻŦেāĻļি
āĻāĻ–āύ liver āύāϤুāύ āĻĒ্āϰোāϟিāύ āϤৈāϰি āĻŦা⧜ি⧟েāĻ“ āĻāϟা compansate āĻ•āϰāϤে āĻĒাāϰে āύা
āĻ•াāϰāύ liver 10-12 gm/day āĻšাāϰে protein āĻŦাāύা⧟ āĻ…āύ্āϝāĻĻিāĻ•ে 3.5+gm/day loss āĻšā§Ÿ
āϏাāĻĨে proximal convoluted tubule āĻŦেāĻļ āĻŦ⧜ āĻāĻŽাāωāύ্āϟ protein āĻ–ে⧟ে āĻĢেāϞে-
āĻĢāϞে āχāωāϰিāύ āĻ 3.5+gm/day loss āĻšāϞেāĻ“ āφāϏāϞে āĻāϰ āĻĨেāĻ•ে āĻ…āύেāĻ• āĻŦেāĻļি circulation āĻĨেāĻ•ে āĻŦেāϰ āĻšā§Ÿ āϝা āĻ•োāύ āĻ­াāĻŦেāχ liver āϏাāĻŽাāϞ āĻĻিāϤে āĻĒাāϰে āύা
[āĻāχāĻ–াāύে āφāĻŽাāϰ āφāĻ—ে āĻ—্āϰāĻĒ āĻ āĻļে⧟াāϰ āĻ•āϰা edema āĻāϰ āϞেāĻ–াāϟা āĻĒ⧜ুāύ, āύা āĻšāϞে āĻŦুāĻāϤে āĻšā§ŸāϤ āϏāĻŽāϏ্āϝা āĻšāĻŦে]
āĻāĻ–āύ protein circulation āĻĨেāĻ•ে āĻŦেāϰ āĻšā§Ÿে āϝাāϚ্āĻ›ে āφāϰ fluid interstitium āĻĨেāĻ•ে capillaries āĻ āĻŦ্āϝাāĻ• āφāϏāϞো āύা- āĻāϤে edema form āĻ•āϰে। āĻāχ edema āϏাāϰা āĻĻেāĻšেāχ āĻšā§Ÿ- āϤাāχ āĻāϟা generalize edema āĻŦা anasarca
*** renal cause āĻ edema āφāĻ—ে āϚোāĻ–েāϰ āĻĒাāĻļে āĻŦা āĻŽুāĻ–ে āĻšā§Ÿ- āĻ•াāϰāύ āĻāχ āϝা⧟āĻ—াāϤ āϟিāϏ্āϝু āϞুāϜ- āĻĢāϞে āϏāĻšāϜেāχ edema fluid āϜāĻŽে āϝা⧟।
āĻāχ edema pitting āύা non pitting?
[āĻāχāĻ–াāύে āφāĻŽাāϰ āφāĻ—ে āĻļে⧟াāϰ āĻ•āϰা edema āĻāϰ āύোāϟ āĻĻেāĻ–ুāύ]
āĻāĻ–āύ ā§§āĻŽ mechanism āĻ edema āĻšāϞ
āĻāχ āϏāĻŽā§Ÿ edema āĻāϰ āϜāύ্āϝ vessel āĻ fluid āĻ•āĻŽে āϝা⧟- āĻ•াāϰāύ āϏেāχ fluid āχ āϤো interstitium āĻ āϝাāϚ্āĻ›ে
āĻĢāϞে Renin Secretion āĻŦা⧜āĻŦে āϝা angiotensin mechanism āĻāϰ āĻŽাāϧ্āϝāĻŽে vesoconstriction āĻ•āϰāĻŦে- āϝা āφāϰো edema āĻ•āϰāĻŦে
āφāĻŦাāϰ
āĻāχ edema āĻāϰ āĻĢāϞে vessel āĻ fluid āĻ•āĻŽে āϝাāϚ্āĻ›ে
āĻĢāϞে aldosteron release āĻšā§Ÿে Na āĻ“ water reabsoption āĻŦা⧜াāĻŦে
āĻĢāϞে āφāϰো āĻŦেāĻļি edema āĻšāĻŦে
āφāĻŦাāϰ edema āĻāϰ āĻ•াāϰāύে blood osmolarity āĻŦা⧜āĻŦে āϝা brain āĻ hypothalamus āĻ•ে stimulate āĻ•āϰে ADH secration āĻŦা⧜াāĻŦে- āĻāϤে āφāϰো water retention āĻšā§Ÿে āφāϰো āĻŦেāĻļি edema āĻšāĻŦে
āĻāĻ­াāĻŦে ā§§ āϟা āĻŽেāχāύ āĻ•াāϰāύ āφāϰ āϏাāĻĨে āφāϰো ā§Š āϟা āĻ•াāϰāύে edema āĻšā§Ÿে āϚāϞāĻ›ে
āĻ•িāύ্āϤু āĻāĻ•āχ āϏাāĻĨে āφāĻŽাāĻĻেāϰ liver āϚাāχāĻŦে protein āĻāϰ āĻĒāϰিāĻŽাāύ āĻŦা⧜াāϤে- āĻŽাāύে āĻ‰ā§ŽāĻĒাāĻĻāύ āĻŦা⧜াāϤে
āϏāĻŽāϏ্āϝা āĻšāϞ liver āĻ protein āĻāϰ āϏাāĻĨে lipoprotein āϤৈāϰি āĻšā§Ÿ
āĻāϤে LDL,VLDL, TG āϏāĻŦ āĻŦা⧜ে āφāϰ HDL āĻ•োāύ āĻ•োāύ āĻ•্āώেāϤ্āϰে āĻ•āĻŽে। āĻāĻ•াāϰāύে āĻŦāϞা āϝাāĻŦে Hyperlipidemia or dyslipidemia āĻšāϚ্āĻ›ে
āĻāĻ­াāĻŦে, protein loose (+3.5 gm/day), āϞিāĻĒিāĻĄ āĻŦে⧜ে āϝাāĻ“ā§Ÿা āĻŦা edema āĻšāĻ“ā§Ÿা āχ Nephrotic syndrome
pore āĻĻি⧟ে āϝে āĻļুāϧু albumin pass āĻ•āϰāĻŦে āϤা āύা। āĻŦāϰং āφāϰো āĻ›োāϟ āϏাāχāϜেāϰ āĻ•িāĻ›ু protein āĻ“ āϚāϞে āϝাāĻŦে
āϝেāĻŽāύ Transferrin
āĻāϟা urine āĻ pass āĻšāĻŦাāϰ āĻšāύ্āϝ Iron Deficiency Anemia āĻšāĻŦে
āφāĻŦাāϰ āĻ…āύেāĻ•āĻĻিāύ Nephrotic syndrome āĻĨাāĻ•āϞে āĻ•িāĻ›ু anti-thrombin III āĻ“ urine āĻ āϚāϞে āϝাāĻŦে- āĻĢāϞে āφāĻŽাāĻĻেāϰ body thrombotic tendency āĻĻেāĻ–াāĻŦে
āφāĻŦাāϰ Nephrotic syndrome āĻ complement āĻ“ āϞāϏ āĻšāĻŦে। āĻĢāϞে āĻĻেāĻš immune compromise āĻšā§Ÿে āϝাāĻŦে
-----------------------------------------------------------------------
Ref. Dr Najeeb Hand Note. Pathoma, Lecturio
------------------------------------------------------------------------------
-------------------------------------------------------------------------------
āĻāχ āĻĒোāϏ্āϟ āĻāϰ āĻļেāώে āĻ•োāύ āĻĒ্āϰāĻļ্āύ āĻĨাāĻ•āϞে āĻ•āϰāϤে āĻĒাāϰেāύ। āϤāĻŦে āωāϤ্āϤāϰ āφāĻŽি āχ āĻĻিāĻŦ āĻāϟা āĻ­াāĻŦāĻŦেāύ āύা- āφāĻŽি āύিāϜেāχ "āĻŦিāĻĻ্āϝাāϰ āϜাāĻšাāϜ"
-------------------------------------------------------------------------------
āφāĻ—েāϰ āĻĒোāϏ্āϟ āĻāϰ āϰিāĻ•্āϝাāĻĒ- āϚাāχāϞে āϏ্āĻ•িāĻĒ āĻ•āϰুāύ
āĻ—্āϞোāĻŽেāϰুāϞাāχ āĻ pore, slit āχāϤ্āϝাāĻĻি āĻŦ্āϝাāϰি⧟াāϰ āĻšিāϏাāĻŦে āĻ•াāϜ āĻ•āϰāĻ›িāϞ। pore 20-30 nm āφāϰ slit 70-100 nm āĻĨাāĻ•া⧟ āĻāϰ āĻĨেāĻ•ে āĻ›োāϟ molecule āχ āĻ•েāĻŦāϞ āĻĒাāϏ āĻ•āϰāϤে āĻĒাāϰāϤো।
āĻāϞāĻŦুāĻŽিāύ āĻāϰ āĻĨেāĻ•ে āĻ›োāϟ āĻĨাāĻ•াāϰ āĻĒāϰেāĻ“ āĻĒাāϏ āĻ•āϰāϤো āύা āϏাāϧাāϰāύ āĻ…āĻŦāϏ্āĻĨা⧟ āĻ•াāϰāύ āĻāϞāĻŦুāĻŽিāύ āĻāϰ āύেāĻ—েāϟিāĻ­ āϚাāϰ্āϜ āφāϰ āĻāχ āĻŦ্āϝাāϰি⧟াāϰ āĻ—ুāϞোāϰ āĻ“ āύেāĻ—েāϟিāĻ­ āϚাāϰ্āϜ
āĻ—্āϞোāĻŽেāϰুāϞাāχ āĻ āχāύāϜুāϰি āĻšāϞে āύাāύা āϏāĻŽāϏ্āϝা āĻšāϚ্āĻ›িāϞ- āϝাāϰ āωāĻĻাāĻšāϰāĻŖ āĻĻেāĻ“ā§Ÿা āĻšā§ŸেāĻ›িāϞ āφāĻ—েāϰ āĻĒāϰ্āĻŦে।
āĻ•িāϰāĻ•āĻŽ?
āĻ…āϞ্āĻĒ injury āĻšāϞ- āĻāϤে āĻ…āϞ্āĻĒ pore āϤৈāϰি āĻšāϞ- āϝা āĻĻি⧟ে albumin pass āĻ•āϰāϞো āĻ•িāύ্āϤু pore āĻāϰ āϏাāχāϜ āĻāϤো āĻŦ⧜ āύা āϝা āĻĻি⧟ে āĻ—্āϞোāĻŦিāωāϞিāύ āĻĒাāϏ āĻ•āϰāĻŦে
āĻ…āϰ্āĻĨাā§Ž selective proteinuria
āφāĻŦাāϰ āφāϰো āĻŦেāĻļি āχāύāϜুāϰি āĻšāϞ-
pore āφāϰো āĻŦ⧜ āĻšāϞ
āĻāϤে āĻāϞ্āĻŦুāĻŽিāύ āφāϰ āĻ—্āϞোāĻŦিāωāϞিāύ āĻĒাāϏ āĻ•āϰāϞো - āĻāϟা āĻ•ে āĻŦāϞা āĻšā§ŸেāĻ›িāϞ non selective proteinuria
āĻ•িāύ্āϤু āĻāϏāĻŽā§Ÿ āĻāχ āĻĒ্āϰোāϟিāύ āĻāϰ āĻĒāϰিāĻŽাāύ 3.5 gm/day āĻāϰ āĻ•āĻŽ āĻĨাāĻ•া⧟ āĻāϟাāĻ•ে
non-selective proteinuria in sub-nephrotic range āĻŦāϞা āϝাāĻŦে
āĻāϰāĻĒāϰ āφāϰো āĻŦেāĻļি injury āĻšāϞ- āĻāϤে āφāϰো āĻŦেāĻļি āĻĒāϰিāĻŽাāύে āĻĒ্āϰোāϟিāύ āĻŦেāϰ āĻšāϞ urine āĻ
āĻāϟা āĻšāϞ non-selective or selective proteinuria in nephrotic range [āĻ…āύেāĻ• āϏāĻŽā§Ÿ āĻŦেāĻļি injury āϤে āĻŦ⧜ āĻŦ⧜ pore āϤৈāϰি āĻšā§Ÿ āĻŦ্āϝাāϰি⧟াāϰ āĻ āĻ•িāύ্āϤু āĻ…āϞ্āĻĒ āϏংāĻ–্āϝāĻ•। āφāĻŦাāϰ āĻŦেāĻļি āϏংāĻ–্āϝāĻ• pore āĻšāϤে āĻĒাāϰে āĻ›োāϟ āϏাāχāϜেāϰ... āϤাāχ selective or non-selective ]
āĻāχ āϏāĻŽā§Ÿ āφāĻŽāϰা ā§Š āϟা āχāĻ­েāύ্āϟ āĻĒাāϚ্āĻ›িāϞাāĻŽ-
ā§§) Heavy proteinuria [āϏাāĻĨে Hyperlipidemia and hyperlipideuria]
⧍) Hypoproteinemia
ā§Š) Generalized edema [anasarca] [1st in face and orbital region]
-------------------------------------------------------------------------------
āĻāĻ–āύ āĻāχ āĻĒেāĻļেāύ্āϟেāϰ āφāϰো āĻŦেāĻļি Glomeru;ar injury āĻšā§Ÿে āĻ—েāϞো āĻāϤে pore āĻāϰ āϏাāχāϜ āĻŦ⧜ āĻšāĻŦে āφāϰ number āĻ“ āĻŦেāĻļি āĻšāĻŦে āĻāϤে non selective proteinuria in nephrotic range āĻšāϞ
āĻāχ āĻĒেāĻļেāύ্āϟেāϰ severe inflammatory reaction āĻšā§Ÿ āφāϰ urine āĻ RBC pass āĻ•āϰāϤে āĻļুāϰু āĻ•āϰে
āĻāχ RBC āĻ—ুāϞা āϏাāϧাāϰāύ shape āĻāϰ āĻšā§Ÿ āύা- āĻŦāϰং star shaped āĻšā§Ÿ - āĻŽূāϞāϤ āĻāϟা āĻĻেāĻ–েāχ āĻŦোāĻা āϝা⧟ āĻāχ hematuria glomerular origin, lower urinary tract injury āύা
āĻāĻ–āύ āĻāχ RBC āĻāĻ•া āĻāĻ•া āϏāĻŦāϟাāχ urine āĻ āĻĒাāϏ āĻ•āϰে āύা- āĻŦāϰং āĻ•িāĻ›ুāϟা āϜāĻŽাāϟ āĻŦাāϧে। āφāĻŦাāϰ āĻ•িāĻ›ু protein āĻāχ RBC āĻ—ুāϞাāĻ•ে āĻāĻ•āϟাāϰ āϏাāĻĨে āφāϰেāĻ•āϟাāĻ•ে āϜāĻŽাāϟ āĻŦাāϧা⧟ āĻĻে⧟।
āϝে āϝা⧟āĻ—া⧟ āĻāχ āϜāĻŽাāϟ āϟা āĻŦাāϧে āϤাāϰ āĻĒিāĻ›āύ āĻĨেāĻ•ে glomerular filtrate āĻāϏে āϧাāĻ•্āĻ•া āĻĻে⧟- āĻĢāϞে āĻāχ āϜāĻŽাāϟ āĻŦাāϧা RBC āĻāĻ•্āϏāĻŽā§Ÿ urine āĻĻি⧟ে āĻŦেāϰ āĻšā§Ÿ
āϝেāĻšেāϤু RBC āĻ•āϤāĻ—ুāϞা āϜāĻŽাāϟ āĻŦাāϧে- āĻāĻĻেāϰ shape āĻšā§Ÿ tubule āĻāϰ shape āĻāϰ āĻŽāϤāύ āχ। āĻāĻ•াāϰāύে āĻāĻĻেāϰ RBC cast āĻŦāϞে (cast= āĻ›াঁāϚ)
āĻ…āύ্āϝāĻĻিāĻ•ে āφāĻ—েāχ āĻŦāϞেāĻ›ি āĻāχāϏāĻŽā§Ÿ inflammatory reaction āĻšā§Ÿ- inflammatory cells āφāϏে āϝাāĻĻেāϰ āĻ•াāϰāύে glomeruli āĻĻি⧟ে blood flow āĻ•āĻŽে āϝা⧟ (āĻŦাāϧা āĻĒা⧟) āĻĢāϞে GFR āĻ•āĻŽāϤে āĻĨাāĻ•ে। āϝāĻ–āύ āĻāχ āĻ­াāĻŦে urine formation 400ml/day āĻšā§Ÿ āϤāĻ–āύ āĻšā§Ÿ oliguria
āĻāĻ–āύ, āĻāχ āĻĒেāĻļেāύ্āϟেāϰ RBC cast āφāĻ›ে- oliguria āφāĻ›ে। āϤাāϰ GFR āĻ•āĻŽ āĻšāϚ্āĻ›ে- āĻĢāϞে āϤাāϰ urea āφāϰ creatinine blood āĻ appear āĻ•āϰে
āĻāϟাāĻ•ে āĻŦāϞে azotemia [āĻāχ waste product urine āĻāϰ āĻŽাāϧ্āϝāĻŽে āĻ•্āϞি⧟াāϰ āύা āĻšāĻ“া⧟ āφāĻŦাāϰ āĻŦ্āϞাāĻĄ āĻ āĻĢিāϰে āϝা⧟]
āφāĻŦাāϰ āĻāχ āĻĒেāĻļেāύ্āϟেāϰ GFR āĻ•āĻŽে āĻ—েāĻ›ে- Renin-angiotensin-aldesteron mechanism āϚাāϞু āĻšā§Ÿ- āĻāχ angiotensin II āĻ–ুāĻŦ āĻļāĻ•্āϤিāĻļাāϞি vasoconstrictor
āĻāϰāĻĢāϞে Hypertension develop āĻ•āϰে āϝাāĻŦে
āϤাāĻšāϞে āĻāĻ–āύ āφāĻŽাāĻĻেāϰ āϏাāĻŽāύে āϝে āϰোāĻ—ী āφāĻ›ে- āϤাāϰ
Hypertension āφāĻ›ে
hematuria āφāĻ›ে [dysmorphic RBC+ RBC cast]
āφāϰ oliguria and azotemia
āĻāχ āĻ…āĻŦāϏ্āĻĨাāχ āĻšāϞ nephritic syndrome
āĻāχ āϏāĻŽā§Ÿে āφāĻ—েāϰ āĻĒেāĻļেāύ্āϟ āĻ—ুāϞা⧟ āĻĨাāĻ•া ā§Š āϟা āχāĻ­েāύ্āϟ āĻ“ āĻĨাāĻ•āϤে āĻĒাāϰে- āϝāĻĨা- ā§§) Heavy proteinuria 2) Hypoproteinemia 3) Generalize edema
āĻāχāĻ–াāύে āĻŽূāϞāϤ mild to moderate glomerular injury short and long time āύি⧟ে āĻšāϞে āĻ•ি āĻšāĻŦে āϏেāϟা āĻŦāϞāĻŦো āφāϰ āĻāĻ•েāĻŦাāϰে āĻļেāώে āĻĒুāϰাāϟা āĻ–ুāĻŦ āĻ…āϞ্āĻĒেāϰ āĻŽাāĻে āϰিāĻ•্āϝাāĻĒ āĻ•āϰāĻŦো
----------------------------------------------------------------------------
āĻšাāϜাāϰ āĻ–াāύেāĻ• āĻŦাāύাāύে āĻ­ুāϞ āφāĻ›ে- āĻ•োāĻĨাāĻ“ āϜāϰুāϰি āϜিāύিāϏ āĻ“ āϏ্āĻ•িāĻĒ āĻ•āϰে āĻ—ি⧟েāĻ›ি āϏāĻšāϜ āϰাāĻ–āϤে। āĻŽূāϞāϤ MBBS level āĻāϰ āϜāύ্āϝ āĻāϟা āϤāĻŦে āĻ•āύ্āϏেāĻĒ্āϟ āĻ•্āϞি⧟াāϰ āύা āĻĨাāĻ•āϞে MD āφāϞাāϰা āĻ“ āĻĒ⧜āϤে āĻĒাāϰেāύ
-----------------------------------------------------------------------------
āĻāĻŦাāϰ āϧāϰেāύ- āύāϤুāύ āφāϰেāĻ•āϜāύ āĻĒেāĻļেāύ্āϟ (āĻĒেāĻļেāύ্āϟ āύাāĻŽ্āĻŦাāϰ ā§Ģ) - āϝাāϰ mild to moderate injury
āϝāĻĨাāϰিāϤি āϤাāϰ GBM āĻ pore āϤৈāϰি āĻšāĻŦে। āϏেāχ pore āĻĻি⧟ে āϏāĻŦ āĻ•িāĻ›ু āĻĻ্āϰুāϤ āĻĒাāϏ āĻ•āϰāĻŦে- [āĻāϞāĻŦুāĻŽিāύ, āĻ—্āϞোāĻŦিāωāϞিāύ, RBC, RBC Cast] āϏেāχ āϏাāĻĨে āĻĒ্āϰāϚুāϰ āĻĒāϰিāĻŽাāύ fibrin molecule āĻ“ āĻĒাāϏ āĻ•āϰে āφāϏāĻŦে āϝা āĻ­িāϏেāϰাāϞ āφāϰ āĻĒ্āϝাāϰাāχāϟাāϞ āĻāĻĒিāĻĨেāϞি⧟াāĻŽ āĻāϰ āĻŽাāĻে āϜāĻŽা āĻšāĻŦে
āĻāχ fibrin molecule āϜāĻŽে āĻĨেāĻ•ে āĻŦিāĻ­িāύ্āύ growth factor release āĻ•āϰāĻŦে āϝা epithelial āĻ•ে proliferate āĻ•āϰাāĻŦে - āĻāχ epithelial āĻ—ুāϞা āĻ•্āϝাāĻĒāϏুāϞেāϰ āĻĒুāϰোāϟাāĻ•ে āĻŦ্āϞāĻ• āĻ•āϰে āĻĻিāĻŦে
āĻāĻ–āύ proximal convoluted tubule āĻāϰ āωāĻĒāϰে Bowmans capsule āϚিāύ্āϤা āĻ•āϰেāύ- āϝা āĻĒুāϰাāϟা āĻŦ্āϞāĻ• āĻšā§Ÿে āĻ—েāĻ›ে- āĻĻেāĻ–āϤে āĻ•েāĻŽāύ? āĻ…āύেāĻ• āϟা āϚাāĻĻেāϰ āĻŽāϤāύ āύা? Red crescent āĻāϰ āϚাঁāĻĻ, āĻāĻ•াāϰāύে āĻāĻ•ে crescent glomerulopathy or crescent glomerulonephritis āĻŦāϞে
āĻāχ āĻ…āĻŦāϏ্āĻĨা⧟ āϜāύাāĻŦ āĻ•িāĻĄāύী āĻĻ্āϰুāϤ āϤাāϰ āĻ•াāϰ্āϝāĻ•্āώāĻŽāϤা āĻšাāϰাāϤে āĻĨাāĻ•ে।
āφāĻ—েāϰ āĻĒেāĻļেāύ্āϟ āĻ (āĻĒেāĻļেāύ্āϟ āύাāĻŽ্āĻŦাāϰ ā§Ē) azotemia āĻšāχāĻ›িāϞ। āĻ•িāύ্āϤু āĻāĻŦাāϰ āφāϰো severe injury (āφāĻ—েāϰ āϟা āĻĨেāĻ•ে) āĻāϤে āĻ•িāĻĄāύী āϤাāϰ āĻ•াāϜ āĻ•āϰাāϰ āĻ•্āώāĻŽāϤা āĻšাāϰাāĻŦে āĻŽাāύে āĻĢিāϞ্āϟাāϰ āĻ•āϰāĻŦে āύা āĻāϤে-
K ion āĻŦা⧜āĻŦে āϝা arrhythmia āĻ•āϰāĻŦে, uremic pericarditis, uremic frost, uremic central nervous system manifestation etc āĻšāϤে āĻĨাāĻ•āĻŦে। āĻ…āϰ্āĻĨাā§Ž uremia āϰিāϞেāϟেāĻĄ āϏāĻŽāϏ্āϝা āĻšāĻŦে due to renal failure
[Note
Azotemia: Biochemistry disturbed but no S/S of renal failure
Uremia: Biochemistry disturbed + S/S of acute renal failure]

[cute renal failure āĻ•াāϰāύ āĻāϟা āĻŦেāĻļ āĻ…āϞ্āĻĒ āĻĻিāύেāχ āĻšāĻŦে। āĻ…āϰ্āĻĨাā§Ž mild to moderate glomerular injury āĻ…āϞ্āĻĒ āĻĻিāύ āĻšāϞে]
āĻāĻ–āύ āĻāχ ā§Ģ āύাāĻŽ্āĻŦাāϰ āĻĒেāĻļেāύ্āϟ āĻ•েāχ āϧāϰেāύ āĻ…āύেāĻ• āĻĻিāύ āϘāϰে āĻĢেāϞে āϰাāĻ–া āĻšāϞ- āĻŽাāύে āϟ্āϰিāϟ্āĻŽেāύ্āϟ āĻĻিāϞাāĻŽ āύা। āĻŦা āĻĄা⧟āĻ—āύোāϏ āĻšāϞ āύা- āϤাāĻšāϞে???
āĻ…āύেāĻ•āĻĻিāύ āϧāϰে mild to moderate glomerular injury āĻšāϞে inflammatory cells āĻ—ুāϞা growth factor āϤৈāϰি āĻ•āϰে [āϝেāĻšেāϤু inflammation āĻšā§ŸেāĻ›ে- āφāϰো āϜাāύāϤে inflammation āĻĻেāĻ–ুāύ]
Long Term Inflammation -> growth factor specially for proliferation and activation of fibroblast and fibroclast
āĻāϰ āĻĢāϞে āĻ—্āϞোāĻŽেāϰুāϞাāχ āĻ āĻ•োāϞাāϜেāύ āĻāϰ āĻĄিāĻĒোāϜিāĻļāύ āĻšā§Ÿ-
āĻŽাāύে āĻ—্āϞোāĻŽেāϰুāϞাāχ āĻĒুāϰা āϏāϞিāĻĄ āĻšā§Ÿ- āϏাāĻĨে āϟিāωāĻŦুāϞ āĻ“ atonic āĻšā§Ÿে āϝা⧟
Nephrologist āϰা āĻāϟা āĻ•ে āĻŦāϞেāύ- Hyalinized kidney/glomeruli
āĻāĻ­াāĻŦে āĻ—্āϞোāĻŽেāϰুāϞাāχ āĻ•োāϞাāϜেāύ āĻ āĻĒূāϰ্āĻŖ āĻšā§Ÿে āϝাāĻ“ā§Ÿা āϤে āĻ•িāĻ›ুāχ āĻĢিāϞāϤাāϰ āĻšāĻŦে āύা- āĻĢāϞে Chronic Renal Failure āĻšāĻŦে (mild to moderate injury for long time)
IN SHORT:
---------------
Pt. 1
+ injury -> small pore in glomeruli -> selective proteinurea (albuminerua)
.
pt. 2
.
++ injury āφāϰেāĻ•āϟু āĻŦেāĻļি -> non selective proteinurea in sub nephrotic range
[non selective: both albumin and globulin]
[sub nephrotic range: less then 3.5 gm/day through urine]
.
pt. 3
.
+++ injury -> heavy proteinurea (selective or non selective) in Nephrotic range -> symptom pyramid [Heavy proteinurea + Hypoprotenimia + G. edema]
[glomerular injury āĻāϰ āĻĢāϞে āϤৈāϰি āĻšāĻ“ā§Ÿা pore āĻ—ুāϞো āĻ…āύেāĻ• āĻŦেāĻļি āϏংāĻ–্āϝāĻ• āĻ•িāύ্āϤু āϏাāχāϜে āĻ›োāϟ āĻšāϞে āĻļুāϧু albumin āĻŦেāϰ āĻšāĻŦে āĻ•িāύ্āϤু 3.5 gm/day āĻāϰ āĻŦেāĻļি āĻšাāϰে। āϤāĻ–āύ selective āφāϰ āϝāĻĻি āĻ…āϞ্āĻĒ āϏংāĻ–্āϝāĻ• pore āĻ•িāύ্āϤু āĻŦ⧜ āĻŦ⧜ āĻšā§Ÿ āϤাāĻšāϞে albumin and globulin āϏāĻŦ āχ āĻŦেāϰ āĻšāĻŦে āĻāχ āϏāĻŽā§Ÿ non-selective]
.
pt. 4
.
++++ injury -> āφāĻ—েāϰ āĻŦাāϰেāϰ āĻŽāϤāχ āϏāĻŦ āĻ•িāύ্āϤু injury āĻŦেāĻļি āĻ–াāϰাāĻĒ- āϤাāχ āφāĻ—েāϰ āĻĒিāϰাāĻŽিāĻĄ āĻāϰ āωāĻĒāϰ āφāϰেāĻ•āϟা āĻĒিāϰাāĻŽিāĻĄ āĻŦāϏāĻŦে। āĻ…āϰ্āĻĨাā§Ž [Heavy proteinurea + Hypoprotenimia + G. edema] + [Hematuria, dysmorphic RBC, cast + HTN + Azotemia, oligourea]
.
=> pt. 5
.
moderate to severe injury for short time -> severe injury, inflammation, inflammatory cells ->fibrin molecule accumulates -> epithelium cells growth and block glomerulus -> crescent glomerulopathy -> acute renal failure
pt.5 with quack doctor
moderate to severe injury -> inflamamtory cells form growth factors for proliferation and activation of fibroblast and fibroclast -> collagen fibers form and block entire nephron -> hyalinized kidney -> chronic renal failure
-------------------------------------------------------------------------------
Ref. āĻĄ āύাāϜীāĻŦ āϞেāĻ•āϚাāϰ āĻš্āϝাāύ্āĻĄ āύোāϟāϏ, āϞেāĻ•āϚুāϰিāĻ“, āĻĒ্āϝাāĻĨোāĻŽা āĻŦāχ
--------------------------------------------------------------

No comments

Theme images by follow777. Powered by Blogger.